Sign In
Buy MREO
$0.334
-0.0052 (-1.53%)
At Close: Jun 03, 2026
Mereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout
11:39am, Monday, 20'th Jun 2022
Shares of Mereo BioPharma (MREO) surge after reports suggest that AstraZeneca (AZN) is interested in acquiring it.
Dow ends lower in mixed finish for U.S. stocks, S&P 500 suffers worst week since March 2020
11:24am, Saturday, 18'th Jun 2022 MarketWatch
U.S. stocks end mixed Friday, with all three major benchmarks closing a choppy session of trade with bruising weekly losses.
Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List
08:34pm, Friday, 17'th Jun 2022 PennyStocks
Can these penny stocks continue to make gains
The post Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List
04:34pm, Friday, 17'th Jun 2022
Can these penny stocks continue to make gains The post Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com
Why Mereo BioPharma Shares Are Jumping Today
10:39am, Friday, 17'th Jun 2022
AstraZeneca plc (NASDAQ: AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ: MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5,
AstraZeneca weighing bid for Mereo BioPharma: report
03:44am, Friday, 17'th Jun 2022
AstraZeneca AZN, +0.48% AZN, +0.42% is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma MREO, +16.03% , The Times reported without attribution. AstraZeneca already is a partner
10 Biggest Price Target Changes For Monday
11:45am, Monday, 06'th Jun 2022 Benzinga
Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday.
Piper Sandler reduced JOANN Inc. (NASDAQ: JOAN) price target from $11 to $6. JO
Mereo BioPharma Announces the Presentation of Updated Data From a Phase 1b/2 Study of Etigilimab as a Poster at the 2022 American Society of Clinical Oncology Annual Meeting
09:05pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
Phase 1b/2 Study of Etigilimab and Nivolumab in Subjects with Select Locally Advanced or Metastatic Solid Tumors (ACTIVATE)
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
08:30pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
LONDON and REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on
Best Penny Stocks To Buy? Einhorn, Lynch, Cohen & Dalio Own These 5
03:04pm, Thursday, 19'th May 2022 PennyStocks
Top Wall Street Investors Own These 5 Penny Stocks. Are They A Buy Now?
The post Best Penny Stocks To Buy? Einhorn, Lynch, Cohen & Dalio Own These 5 appeared first on Penny Stocks to Buy, Picks, News
Best Penny Stocks To Buy? Einhorn, Lynch, Cohen & Dalio Own These 5
11:04am, Thursday, 19'th May 2022
Top Wall Street Investors Own These 5 Penny Stocks. Are They A Buy Now?
What to Know About Trading Penny Stocks on Monday, May 9th
12:00pm, Monday, 09'th May 2022 PennyStocks
Here's what you need to know about trading penny stocks on May 9th
The post What to Know About Trading Penny Stocks on Monday, May 9th appeared first on Penny Stocks to Buy, Picks, News and Informat
What to Know About Trading Penny Stocks on Monday, May 9th
08:00am, Monday, 09'th May 2022
Here's what you need to know about trading penny stocks on May 9th The post What to Know About Trading Penny Stocks on Monday, May 9th appeared first on Penny Stocks to Buy, Picks, News and Informat
Mereo BioPharma Shares Jump After Encouraging Alvelestat Data In Lung Disease
07:47am, Monday, 09'th May 2022
Mereo BioPharma Group plc (NASDAQ: MREO) has announced topline efficacy and safety results from ASTRAEUS Phase 2 study of alvelestat (MPH-966) in severe alpha-1 antitrypsin deficiency-(AATD) associ
Mereo BioPharma to Host Conferene Call Highlighting Top-line Clinical Data from “ASTRAEUS” Phase 2 Study of Alvelestat
09:12pm, Friday, 06'th May 2022 GlobeNewswire Inc.
Call scheduled for Monday, May 9, 2022 at 10:30 a.m. ET Call scheduled for Monday, May 9, 2022 at 10:30 a.m. ET
